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entry, in model Escherichia colimembranes correlates with their ability to permeate membranes without complete
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.with these infections in terms of annual health care costs and productiv-
ity losses are estimated to be as high as $20 billion and $35 billion, re-
spectively [1]. Most antibiotics in clinical use kill or inhibit the growth
of metabolically active bacteria by targeting various biosynthetic pro-
cesses in growing bacteria, including the synthesis of proteins, RNA,
DNA, peptidoglycan, and folic acid [2–5]. For instance, the β-lactam
class of antibiotics, which includes penicillins, cephalosporins, and car-
bapenems, inhibit cell wall synthesis in cells undergoing division. Ami-
noglycoside, macrolide, tetracycline, and other antibiotics target the
bacterial ribosome to inhibit protein synthesis. Resistance can develop
in at least two general ways: biomacromolecules targeted by an antibi-
otic can mutate to minimize or eliminate susceptibility (genetic antibi-
otic resistance), or bacteria can also adapt physiologically to become
quiescent, or slow-growing. These persisting bacteria are able to evade
deleterious effects through the down-regulation of biosynthetic pro-
cesses that are often targeted by conventional antibiotics. Persisting
bacteria are found in chronic infections, such as endocarditis, cystic ﬁ-
brosis, and tuberculosis, which require prolonged treatment periods.
Hence, there is a critical need for new structural classes of antibiotic
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impeded by mechanisms of antibiotic tolerance.
Antimicrobial peptides (AMPs) constitute a critical component of
the eukaryotic innate immune system. Collectively, AMPs have broad-
spectrum antimicrobial activity [6–11]. These host-defense peptides
are diverse in sequence and structure, but two common features are cat-
ionic charge and hydrophobicity [8,9,12–15]. Some AMPs, such as
cecropin and magainin, adopt an amphipathic α-helical secondary
structure, in which cationic and hydrophobic side chains are spatially
segregated from one another, upon interaction with membranes
[8]. Other AMPs, such as bactenecin and defensins, feature anti-
parallel β-sheet structure, around which cationic and hydrophobic re-
gions are segregated. The combination of hydrophobic and cationic sub-
units is believed to play a key role in the antimicrobial activity of AMPs,
enabling the disruption of bacterial membranes through a combination
of electrostatic interactions involving the cationic side chains with the
anionic membrane along with the insertion of hydrophobic side chains
into the nonpolar interior of the lipid membrane bilayer [8–10,16–18].
AMPs can destabilizemembranes through a variety of processes, includ-
ing pore formation, blebbing, budding, and formation ofmixed peptide–
lipid micellar assemblies (“carpet mechanism” [10]). Antimicrobial
agents thatmimic natural AMPs by targeting generic aspects of bacterial
membranes may have potential for treating both antibiotic-resistant
and slow-growing dormant infections. Membrane-disruptive antimi-
crobial agents that directly interact with the bacterialmembrane bilayer
can destabilize and compromise the physical integrity of themembrane.
In general, membrane-targeted approaches have been shown to be clin-
ically effectivewith newer antibiotics such as daptomycin, which is cur-
rently used to treat Staphylococcus aureus infections [2].
Recent work [7,19,20] has shown that the existence of negative in-
trinsic curvature lipids, such as those with phosphoethanolamine (PE)
headgroups, in the targetmembrane is an important determining factor
in whether such membranes are permeated by AMPs: bacterial mem-
braneswith high PE concentrations are vulnerable to AMP-induced per-
meation, while eukaryotic membranes with low PE concentrations are
not. Because many AMPs and synthetic compounds inspired by AMPs
interact directly with membranes, the development of bacterial resis-
tance against these agents is more difﬁcult to achieve than against con-
ventional antibiotics [21–24]. Nonetheless, bacterial resistance, in the
form of reduced susceptibility to AMPs, is still possible through the
modiﬁcation of the membrane composition. Previous work has shown
that bacteria can actively detect AMPs through two-component signal
transduction systems, such as PhoQP in Gram-negative bacteria and
GraSR in Gram-positive bacteria, and respond by altering their mem-
branes [21,25–33]. However, a PE deletion, which would essentially
confer immunity against membrane-active antibiotics, is found to be le-
thal in bacteria. This may help explain the unexpected absence of bacte-
rial strains resistant to AMPs despite repeated exposure [19]. Thus, with
increased clinical prevalence of bacterial resistance to conventional an-
tibiotics, interest has grown in the prospect of using antimicrobial pep-
tides as therapeutic agents, and in designing new antibiotics inspired by
AMPs.
The attractive properties of natural AMPs have inspired extensive ef-
fort to develop synthetic analogues. Such efforts have included both
oligomers of α-amino acids (α-peptides) [34–36] and oligomers that
contain unnatural subunits, such as β-peptides [37–40], α/β-peptides
[41,42], peptoids [43], and aromatic oligomers [44–48]. These AMP an-
alogs have been demonstrated to provide various potential advantages
over conventional antibiotics: (1) tunable, custom designs, (2) ease in
preparation, (3) cost-effectiveness, (4) antibacterial potency with re-
duced likelihood of resistance, and (5) allowance for additional new
built-in functions. In fact, recent work has highlighted quantitative dif-
ferences between natural AMPs and their present synthetic analogs in
terms of their hydrophobic content and cationic charge [49]. However,
all unnatural AMP-mimetic oligomers have speciﬁc sequences of sub-
units, which require solid-phase synthesis, a technique that is costlyand therefore not practical for many applications [6]. This situation
has prompted a number of groups to explore synthetic polymers
as a novel source of AMP mimics over the past decade. In contrast to
α-peptides and other sequence-speciﬁc oligomers, for which every
molecule in a given sample is in principle identical, materials generated
via polymerization reactions are mixtures, with variations in chain
length and, for co-polymers, in subunit sequence. However, polymer
production is much less expensive than production of sequence-
speciﬁc oligomers. Early studies revealed that polymers with high in-
trinsic hydrophobicity could be effective against bacteria but not cell-
type selective, since these materials are hemolytic [44,47,48,50]. More
recently, polymers with carefully tuned hydrophobic-hydrophilic bal-
ance have been shown to match the generic AMP activity proﬁle:
inhibiting bacterial growth at low concentrations but causing hemolysis
only at much higher concentrations [51–55]. Nylon-3 polymers have
proven to be quite promising in this regard [51,53]. The nylon-3 back-
bone, comprised of β-amino acid residues, should be similar to the
polyamide backbone of proteins in terms of physicochemical properties.
Binary hydrophobic-cationic nylon-3 materials are readily prepared via
anionic ring-opening polymerization of appropriate pairs of β-lactams
[56].
In recent work, we have found that the bactericidal activity of a
broad range of peptidic antimicrobials is correlated with the induction
of negative Gaussian membrane curvature (NGC), also known
as saddle-splay curvature, which enables membrane destabilizing
processes such as pore formation, blebbing, and budding. All the
membrane-active antimicrobials examined induce negative Gaussian
curvature when the target membrane lipid compositions mimic those
of bacterial membranes, but not when the lipid compositions are more
representative of mammalian membranes. A key parameter for activity
in this broad range of compounds is the concentration of negative in-
trinsic curvature (C0 b 0) lipids, such as those with PE head groups,
which exist at signiﬁcantly higher concentrations in bacterial cytoplas-
mic membranes compared to eukaryotic membranes. Existence of ho-
mologous behavior in synthetic antimicrobials [19,20,57] suggests a
common root mechanism for selective membrane permeation. In fact,
the trends observed for antimicrobial-lipid interactions are consistent
with killing assays using Escherichia colimutants engineered to have dif-
ferent amounts of PE lipids in their cytoplasmic membranes [19]. Im-
portantly, we have deduced a criterion for amino acid compositions of
AMPs based on the requirement for generating saddle-splaymembrane
curvature, and we have shown that this criterion is consistent with
trends in amino acid composition of 1080 known cationic AMPs [7].
Most biophysical studies of interactions between AMPs and mem-
branes examinemembrane behavior at a single lipid composition. How-
ever, bacterial membranes are known to exhibit different membrane
compositions, which can be modulated in response to antimicrobials
[58–65]. To complicate matters further, natural AMPs are intrinsically
multifunctional. While many AMPs have membrane activity, it is
known they also can bind intracellular targets [66–68] and have
immunomodulating activities [6,69,70]. Due to these complications
and others, it has been hard to correlate biophysical parameters,
such as vesicle leakage and permeability, with antibacterial potency in
general [9].
In this work, we examine a more circumscribed problem. We study
the antimicrobial activity and membrane permeation activity of a set of
nylon-3 polymers, including some that show AMP-like activity proﬁles.
We show that this family of antimicrobial polymers is capable of two in-
terdependent mechanisms of activity, one based on membrane perme-
ation and one onDNA binding. Interestingly, at theminimal bactericidal
concentration (MBC), the extent of bacterial membrane permeation, as
measured by a β-galactosidase-based colorimetric assay on an E. coli
ML-35 strain, is modest and clearly not enough to solubilize the entire
membrane. All members of this family of antimicrobial polymers have
sufﬁcient local surface charge density to bind efﬁciently to intracellular
DNA, in a manner similar to AMPs indolicidin [67] and buforin [68];
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the bacterial membrane. We systematically investigate polymer-
induced membrane deformation modes in a range of lipid concentra-
tions found in E. coli and in mammalian cells using synchrotron small-
angle X-ray scattering (SAXS). Our study includes three nylon-3 poly-
mers with three compositions, tBuBz-MM63CH37 (A), Ac-MM63CH37
(B), and tBuBz-DM50CH50 (C-1, C-2, and C-3) (Fig. 1). Three different
batches of the tBuBz-DM50CH50 polymer were used for these studies,
designated C-1, C-2, and C-3. These batches differ slightly with respect
to average chain length (n = 27, 25, and 21, and molecular weights of
5129, 4590, and 4018 Da for Polymers C-1, C-2, and C-3, respectively)
and show highly similar activity proﬁles (see Supplemental Informa-
tion). We ﬁnd that the existence of NGC, which allows permeation of
membranes and cellular entry of these antibacterial polymers in a man-
ner reminiscent of cell-penetrating peptides, correlates well to their
abilities to disrupt the membranes of and kill E. coli, a representative
Gram-negative bacteria species [45–47]: polymers that have low mini-
mum inhibitory concentrations (MICs) induce cubic phases rich in NGC,
whereas polymers with high MICs do not induce such phases. While all
of the nylon-3 polymers can bind to DNA, not all of them can permeate
membranes, which explains their large observed range of MICs. Taken
together, these results suggest that the nylon-3 polymers have a
concentration-dependent mechanism of action. At concentrations near
the MBC, they can permeate membranes without total membrane dis-
ruption and kill bacteria by binding intracellular targets such as DNA.
However, at concentrations signiﬁcantly higher than the MBC, they
can potentially completely disrupt membranes. Furthermore, we ﬁndFig. 1. Polymer structures. Sequence-random nylon-3 polymers of general structure (a) w
(cyclohexyl), DM (dimethyl), and MM (monomethyl) (b–d). Because the monomers were
DM50CH50 (C-1, C-2, andC-3)were heterochiral. In this study,we examine several representativ
result from the β-lactam utilized in the polymerization, with R1 and R2 groups corresponding to
and 21, and molecular weights of 3458, 5174, 5129, 4590, and 4018 Da for A, B, C-1, C-2, and Cthe two-component mechanism of these polymers to be analogous
to the mode of action employed by certain natural AMPs, such as
indolicidin and buforin.
2. Material and methods
2.1. Polymer synthesis
Polymers were prepared from two types of β-lactam, some that
lead ultimately to cationic subunits, MM (“monomethyl”) or DM
(“dimethyl”), and others that provide lipophilic subunits, CH
(“cyclohexyl”) [51,53,71,72]. All polymerizations were carried out in a
N2-purged dry box at room temperature. In a typical polymerization re-
action, β-lactammonomers were weighed out in the appropriate molar
ratio and placed in a reaction vial. To the vialwas then added anhydrous
THF and tbuBzCl or acetyl chloride (co-initiator) to achieve the desired
monomer:co-initiator ratio and amonomer concentration of 0.1 M. The
mixture was allowed to stir until all materials had dissolved. Polymeri-
zation was initiated by addition of Li(NSiMe3)2 solution (2.5 equivalent
to the starting co-initiator concentration) in THF. The resulting solution
was stirred for 3–4 hours at room temperature. The reaction vialwas re-
moved from glove box, and the polymerization was quenched by
adding 3–4 drops of methanol. The resulting polymer was precipitated
by pouring the solution into pentane. The solidwas isolated by centrifu-
gation, and the supernatant liquid was decanted off. The solid was re-
dissolved in THF and then re-precipitated with pentane. After two
more repetitions of precipitation/centrifugation procedure, the whiteere synthesized using hydrophobic and cationic β-lactam monomers classiﬁed as CH
racemic, the resulting polymers tBuBz-MM63CH37 (A), Ac-MM63CH37 (B), and tBuBz-
emembers from these subfamilies (e–i). The C-terminal imide units on the polymer chains
the side chains of these β- lactams. Polymers have average chain lengths of 18, 27, 27, 25,
-3, respectively.
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Boc group was carried out by dissolving the polymer in 2 mL neat
triﬂuoroacetic acid. The reaction vessel was placed on a shaker for
2 hours (room temperature). The resulting solution was poured into
cold ether to cause the deprotected polymer to precipitate. The solid
was isolated by centrifugation, and the supernatant liquidwas decanted
off. The solid was dried under a stream of N2. The precipitate was
washed with ether twice and dried under vacuum. The material was
then dissolved in 5–10mL of water and lyophilized to yield the polymer
as white ﬂuffy solid.
2.2. Vesicle dye leakage experiments
Giant unilamellar vesicles (GUVs) composed of DOPS (1,2-dioleoyl-
sn-glycero-3-phospho-L-serine (sodium salt))/DOPE (1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine)/DOPC (1,2-dioleoyl-sn-glycero-3-
phosphocholine) = 20/60/20 were prepared encapsulated with
10 mM HEPES, 40 mM Calcein AM dye (pH 7). GUVs were synthesized
using a freeze–thawmethod and extruded through a 0.4 μm pore ﬁlter.
The vesicles were then collimated and suspended in 100 mM NaCl,
10 mM MES buffer at a 1:12 dilution. A spectroﬂuorimeter was used
to examine leakage in these vesicles, with excitation at 490 nm and
emission at 510 nm. The baseline intensity of the vesicle solution was
determined before polymer C-1 solution was added in pre-determined
polymer to lipid (P/L) molar ratios. The resulting increase in ﬂuores-
cence intensity was indicative of vesicle leakage, and addition of 20%
Triton X-100 was used to establish 100% leakage levels by fully
permeabilizing the vesicle membranes. Percent leakage of calcein
from vesicleswasmeasured over a period of about 18 minutes. Polymer
solution and Triton X-100 were added to vesicles at approximately
3 minutes and 16 minutes, respectively.
2.3. E. coli ML-35 membrane permeability assay
E. coli ML-35 strain was a generous gift from Professor André J.
Ouellette at the University of Southern California. This particular E. coli
strain is characterized by its lactose permease deﬁciency but constitu-
tive β-galactosidase activity. Accordingly, it is unable to uptake the lac-
tose analog o-nitrophenyl-β-D-galactopyranoside (ONPG) unless it is
permeabilized by membrane-disruptive agents. Upon membrane per-
meation, ONPG diffuses into the bacterial cell cytoplasm and is hydro-
lyzed by β-galactosidase to yield o-nitrophenol (ONP), which can be
measured by absorbance at 405 nm [73]. E. coli ML-35 cells were
grown up in TSB at 37 °C for 18 hours to reach stationary phase. A
50 μL culture was diluted with fresh TSB by 100-fold and regrown at
37 °C for approximately 2 hours to reach mid-log growth phase, with
an optical density (OD) at 600 nm of 0.5–0.7. Log-phase E. coli ML-35
cells were washed three times and resuspended in 100 mM NaCl,
10 mM MES (pH 7) to approximately 1 × 108 CFU/mL. In a 96-well
plate, 15 μL of bacteria suspension was exposed to polymers (at speci-
ﬁed concentrations) in the presence of 2.5 mM ONPG, 1% TSB,
100 mM NaCl, 10 mM MES (pH 7) for approximately 80 minutes at
37 °C. The kinetics of ONPG hydrolysis to ONP was measured by absor-
bance at 405 nm using a Tecan Inﬁnite 200 microplate reader. Polymer
C-1was assayed in quadruplicate for concentrations of 0, 10, 25, 50, and
200 μg/mL.
2.4. Minimum bactericidal concentration (MBC) assay
Frozen stock of E. coliDH5-α strain (Invitrogen) was streaked onto a
fresh tryptic soy broth (TSB) agar plate and grown overnight at 37 °C. A
single colony sourced from the streaked agar plate was used to grow up
a new culture in TSB overnight in a 37 °C shaker. Bacteria from over-
night culture was added to fresh TSB and shaken at 37 °C for 2 hours
to achieve log-phase bacteria. E. coli was diluted down with additional
TSB to a working density of ~5 × 106 CFU/mL. In a 96-well plate,180 μL each of eight concentrations of polymer C-1 solubilized in
100 mM NaCl, 10 mM HEPES (pH 7) was mixed with 20 μL of working
bacteria solution, to achieve a total volume of 200 μL in each of the
eight wells. Final concentrations of polymer C-1 for these wells were
0, 1, 2, 2.5, 3, 3.5, 4, and 5 μg/mL. The plate was shaken at 37 °C for
1.5 hours. Reaction mixtures were then diluted 1:100 in 100 mM
NaCl, 10 mM HEPES (pH 7); 100 μL of the each of the eight dilutions
was plated onto TSB agar plates in 10× 10 μL drops. Bacterial cell surviv-
al was determined by counting CFU after overnight growth at 37 °C and
scaling up by the dilution factor, and expressed as a function of polymer
concentration. The assay was completed in triplicate on the same day.
2.5. Liposome preparation for X-ray measurements
DOPS, DOPE, DOPC, DOPG (1,2-dioleoyl-sn-glycero-3-[phospho-rac-
(1-glycerol)] (sodium salt)), and CL (bovine heart cardiolipin (sodium
salt)), lyophilized lipids from Avanti Polar Lipids, were used without
further puriﬁcation. For X-ray experiments, small unilamellar vesicles
(SUVs) were prepared by sonication. Individual lipid stock solutions of
DOPS, DOPE, DOPC, DOPG, and CLwere prepared in chloroform at a con-
centration of 20 mg/mL. Mixtures of these lipids were prepared at
molar ratios. Chloroform was evaporated under N2, and the lipid mix-
tures were further dried by overnight desiccation under vacuum. The
dried lipid mixtures were resuspended the following day in 100 mM
NaCl, 10 mM HEPES at pH 7, unless speciﬁed at pH 5 conditions
(100 mM NaCl, 10 mM NaOAc), to a ﬁnal concentration of 20 mg/mL.
Aqueous lipid solutions were incubated at 37 °C overnight and then
sonicated until clear. SUVs were obtained via extrusion of sonicated
lipid solution through a 0.2 μm pore Nucleopore ﬁlter (Whatman).
2.6. λDNA preparation for X-ray measurements
Lambda DNA (1250 μg) was purchased from New England Biolabs;
40 μL of (refrigerator) chilled 3 M NaOAc and 5 μL of 0.3 M MgCl2 were
added into the λDNA vial. The mixture was then centrifuged at
4000 rpm for 1 minute at room temperature and cooled in the refrigera-
tor for 20 minutes. A total of 800 μL of (freezer) chilled 100% ethanol was
subsequently added to the mixture and then placed in the freezer over-
night. The mixture was then centrifuged at 13,500 rpm for 10 minutes
on the following day. The supernatant was removed and the precipitate
washed by adding 1mL of (freezer) chilled 100% ethanol and centrifuged
at 15,000 rpm for 10 minutes at 0 °C. Supernatant was removed again
and the precipitatewaswashed again, by adding 1mL of (freezer) chilled
70% ethanol and centrifuged at 15,000 rpm for 2 minutes at 4 °C. The su-
pernatant was removed and 70% ethanol wash was repeated. Once the
supernatant was removed, the vial was inverted to drip dry onto ﬁlter
paper for at least 2 hours. The λDNA was then reconstituted in
100 mM NaCl, 10 mMMES (pH 7).
2.7. Small-angle X-ray scattering experiments
Polymers and lipid solutions were mixed at speciﬁc P/L molar ratios
and sealed in quartz capillaries (Hilgenberg GmbH, Mark-tubes). Sam-
ples were prepared in 100mMNaCl, 10mMHEPES at pH 7, unless indi-
cated for pH 5 conditions (100 mM NaCl, 10 mM NaOAc). For λDNA
samples, λDNA was mixed with polymer C-3 at speciﬁed polymer to
λDNA (P/D) charge ratios in 100 mM NaCl, 10 mM MES (pH 7) and
sealed in quartz capillaries. SAXS experiments were conducted at the
Stanford Synchrotron Radiation Lightsource (SSRL, BL 4-2) and at
the Advanced Light Source (ALS, beamline 7.3.3), using monochromatic
X-rayswith energies of 9–11keV and 10keV, respectively. The scattered
radiation was collected using a Rayonix MX225-HE detector (pixel size
of 73.2 μm) at SSRL and a Pilatus 100k detector (pixel size of 172 μm) at
ALS. No radiation damage was observed for the incident beam intensi-
ties and the exposure times used. 2D SAXS powder patterns were inte-
grated using the Nika 1.50 package [74] for Igor Pro 6.31 and FIT2D [75].
Pol
Fig. 2. Leakage, permeabilization, and bactericidal assays demonstrate polymer antimi-
crobial activity. Polymer C-1 was shown to induce vesicle leakage, permeate E. coli
membranes, and kill E. coli. (a) Polymer C-1 was exposed to DOPS/DOPE/DOPC = 20/60/
20 vesicles encapsulated with calcein dye at P/L ratios of 1/28.3 and 1/56.7, which
correspond to polymer concentrations of 1.99 and 0.995 μg/mL, respectively. Percent
leakage of calcein from vesicles was measured over a period of approximately 18 minutes.
Polymer and Triton X-100 were added to vesicles at approximately 3 minutes and 16
minutes, respectively. (b) Polymer C-1was incubated with ML-35 E. coli to assess its ability
to permeate bacterial membranes. Membrane permeation was assessed by the amount of
ONP produced, which was measured with absorbance at 405 nm. Polymer C-1was added
at approximately 3 minutes. The reported data are the average of four trials. (c) DH5α
E. coli were exposed to polymer C-1 to determine its bactericidal ability. MBC of polymer
C-1was approximately 3.5 μg/mL forDH5α. Plot depicts themeanCFU/μL value at eachpoly-
mer concentration. Error bars represent the standard deviation of the three trials.
2273M.W. Lee et al. / Biochimica et Biophysica Acta 1838 (2014) 2269–22792.8. SAXS data ﬁts
Q positions of the diffraction peaks were obtained by visual inspec-
tion of the integrated scattering intensity I(Q) vs. Q SAXS data graphed
in Origin Lab software. The ratios among thesemeasured peak positions
(Q(hkl)meas)were comparedwith the ratios of permitted reﬂections for dif-
ferent crystal phases to identify the phases present in the sample. After
determining the crystal phase, its lattice parameter was calculated by
the slope of the linear regression through the set of points corresponding
to the reﬂections, with each point designated by coordinates of Q(hkl)meas
and the associated reﬂection (in terms of Miller indices, h, k, l). For a
powder-averaged cubic phase Q(hkl)meas = (2π/a)√(h2 + k2 + l2). We
take the linear regressions of Q(hkl)meas vs. √(h2 + k2 + l2) for cubic
phases, and from its slope (m= 2π/a), we can back out the cubic lattice
parameters. SAXS data from λDNA samples were schematically repre-
sented using VMD software [96].
2.9. Bacterial growth inhibition (minimum inhibitory concentration (MIC))
assay
Assays were performed as previously reported with moderate
changes in the procedure [39]. The bacteria used in these assays were
E. coli JM109 [76], Bacillus subtilis BR151 [77], S. aureus 1206 (methicil-
lin-resistant) [78], and Enterococcus faecium A634 (vancomycin-resis-
tant) [79]. Antibacterial activities were determined in sterile 96-well
plates. Bacterial cells were grown overnight at 37 °C on agar, after
which a bacterial suspension of approximately 2 × 106 CFU/mL in
Luria Bertani or Brain-Heart Infusion growth medium was prepared.
Samples (50 μL) of this suspensionwere added to 50 μL of medium con-
taining the polymer in 2-fold serial dilutions for a total volume of 100 μL
in eachwell. The plates were then incubated at 37 °C for 6 hours. Bacte-
rial growth was determined by measuring the OD at 650 nm using a
Molecular Devices Emax precision microplate reader. Positive control
was OD without addition of polymer and negative control was OD of
the medium without inoculum. The MIC is deﬁned as the lowest con-
centration at which complete inhibition of bacterial growth was ob-
served (no increase in OD over the course of the experiment). Assays
were performed in duplicate for two separate experiments.
3. Results and discussion
3.1. Nylon-3 polymer C-1 demonstrates antimicrobial membrane activity
through vesicle leakage, membrane permeabilization, and bactericidal
assays
Weexamined the antimicrobial activity of polymer C-1, amember of
the tBuBz-DM50CH50 subfamily, through lipid vesicle leakage, bacterial
membrane permeation, and bactericidal activity experiments.
Vesicle leakage assay
We examined the membrane effects of polymer C-1 with
GUVs using ﬂuorescence spectroscopy. GUVs of lipid composi-
tions of DOPS/DOPE/DOPC = 20/60/20 mimicking PE-rich bacte-
ria membranes were loaded with ﬂuorescent calcein dye and
incubated with polymer C-1 at two polymer/lipid molar ratios:
P/L = 1/28.3 and 1/56.7, which correspond to polymer concen-
trations of 1.99 and 0.995 μg/mL, respectively. Dye leakage was
observed from the GUVs after exposure to the polymer, with
higher P/L generating greater leakage (Fig. 2a). P/L = 1/56.7
reached maximum leakage of approximately 20% after 15 mi-
nutes exposure. P/L= 1/28.3, with twice the quantity of polymer,
reached a maximum leakage of about 40% over the same amount
of time. The leakage results demonstrate the ability of polymer C-
1 to permeabilize model bacteria membranes rich in negative in-
trinsic curvature lipids.ymer-induced permeabilization of E. coli ML-35
To determinewhether polymer C-1 is able to permeabilize actual
bacterial membranes and not just membrane vesicles with simpli-
ﬁed lipid compositions, we conducted an inner membrane perme-
ability assay using the E. coli ML-35 strain. We measured the β-
galactosidase activity of E. coli ML-35 with ONPG as the substrate.
E. coli ML-35 is lactose permease-deﬁcient strain with constitutive
cytoplasmic β-galactosidase activity. Therefore, E. coliML-35 cannot
hydrolyze the lactose analog ONPG unless cells are permeabilized by
membrane-disruptive agents. Upon membrane permeabilization,
ONPG diffuses into the E. coli cytoplasm. As a result, colorless
ONPG is hydrolyzed by β-galactosidase and converted to ONP,
which can be measured by absorbance at 405 nm. Thus, the level
of absorbance corresponds to the level of permeabilization achieved
by a membrane disruptive agent. (We note that permeation may
exist via physical interactions between the polymer andmembrane,
at levels below those detectable in this type of assay.) Such mem-
brane permeabilization assays have been previously utilized to as-
sess the membrane destabilization capabilities of other nylon-3
polymers [52] and AMPs as well [80–83]. For this assay, we tested
concentrations of polymer C-1 up to 200 μg/mL in quadruplicate
(Fig. 2b). Polymer was added at approximately 3 minutes. Increased
absorbance was observed almost immediately upon addition of
polymer C-1 to the E. coliML-35 cells, which suggests potent mem-
brane destabilizing ability. Permeabilization kinetics were found to
increase with increasing polymer concentration.
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To determine the lowest concentration of polymer C-1 required
to achieve bactericidal activity against the DH5-α strain of E. coli,
an MBC assay was conducted. The experiment, completed in tripli-
cate, evaluated polymer C-1 over a range of eight concentrations, 0,
1, 2, 2.5, 3, 3.5, 4, and 5 μg/mL, with each assay consistently arriving
at MBC ~3.5 μg/mL (Fig. 2c). These results show that polymer C-1
has strong activity against E. coli.
Taken together, these results are all mutually consistent, and in-
dicate that membrane permeation is a component of the antimicro-
bial activity of polymer C-1. A quantitative comparison between the
results from the vesicle leakage, membrane permeabilization, and
bactericidal assays is informative. Based on the results from the
ML-35 β-galactosidase activity assay, the amount of membrane per-
meation is relatively modest at the MBC of ~3.5 μg/mL. This consid-
eration suggests that the membrane has not been solubilized at the
MBC, and that membrane permeation is responsible for only a part
of the bactericidal activity of polymer C-1. We propose that another
component of the polymer's antimicrobial effect arises from interac-
tion with bacterial DNA.
Antibacterial nylon-3 polymers are highly cationic, with sufﬁ-
cient local surface charge density to bind to intracellular targets
such as DNA, in a manner similar to AMPs indolicidin [67] and
buforin [68]. An array of closely spaced cationic charges with a
high charge density behaves much differently from the same num-
ber of cationic charges distributed farther apart. For instance, when
a linear charged polymer has a distance between neighboring
charged units of less than the Bjerrum length (~7 Å in water), Man-
ning condensation will cause counterions to condense onto the
charged polymer. Because of this phenomenon, the binding between
cationic polymers and anionic polymers with similar local charge
density is anomalously strong, due to the large entropic gain that re-
sults when the cationic and anionic surfaces charge compensate one
another and release counterionsmaximally [84–87]. Using SAXS, we
conﬁrmed that the nylon-3 polymers we studied are capable ofFig. 3. SAXS spectra show polymer induction of NGC in prokaryotic-likemembranes rich in
mers A, B, and C-2 (a–c). Correlation peaks indexing to the formation of a Pn3m cubic phasewa
charge ratio of 1. An Im3m cubic phasewas inducedwhen vesicleswere exposed to polymer C-2
A andC-2, exposure of lipid vesicles to polymerB resulted in only a lamellar phasewith a period
for comparison.strongly condensing DNA (see Supplemental Information), due to
charge density matching. However, it is possible that other intracel-
lular targets with similar charge densities can also be bound by the
polymer. If we assume one copy of DNA per E. coli cell and complete
chargematching between cationic polymerC-1 andDNA, at theMBC
of 3.5 μg/mL, we estimate that polymer C-1 is able to condense up to
6 × 10−12 g of DNA per cell (see Supplemental Information). This
quantity is ~1000-fold larger than the amount of DNA in a single
E. coli cell [88]. Thus, at the MBC, 0.1% of polymer C-1 molecules
are sufﬁcient to bind all DNA in the cell. Together these results sug-
gest that the overall bactericidal activity of the nylon-3 polymers in-
volve a combination of membrane permeation and DNA-binding
activity. However, it is important to note that DNA binding cannot
occur if the polymer is unable to cross the bacterial membrane,
which we examine in the next section.
3.2. Sequence-randomnylon-3 polymers can generate NGC inmodel bacte-
ria membranes with high PE concentrations but not in model eukaryotic
membranes with low PE concentrations
To investigate themembrane deformations induced by antibacterial
nylon-3 polymers, we employed SUVs with phospholipid compositions
representative of the Gram-negative bacterium E. coli, (DOPG/DOPE =
20/80). These SUVs were incubated with three polymers, A, B, and C-2
(Fig. 1) at a variety of P/L ratios, and the resulting structures were char-
acterized by SAXS. Synchrotron SAXS proﬁles (Fig. 3a–c) from lipid ves-
icle solutions exhibited a broad characteristic feature consistent with a
single lipid bilayer form factor characteristic of unilamellar vesicles.
When exposed to the nylon-3 polymer A, the lipid vesicles undergo a
structural transition, as indicated by two distinct sets of new correlation
peakswith speciﬁc ratios of Q values in the diffraction data (Fig. 3a). One
set of characteristic Q-ratios √2:√3 indexed to the formation of a cubic
(QII) Pn3m “double-diamond” lattice, with lattice parameter aQ_A =
17.29 nm (P/L = 1/57) (see Material and methods for indexing proce-
dures). The other set had integral Q-ratios 1:2:3:4, consistent with a la-
mellar (Lα) phase having a lattice parameter dA≈ 5.18 nm (across all
tested P/L). When vesicles were exposed to C-2, we also observed
two sets of correlation peaks (Fig. 3c). One set had Q-ratios √2:√4:√6,PE. SAXS proﬁles from DOPG/DOPE= 20/80 lipid vesicle solutions after exposure to poly-
s observed for polymerA atmolar ratio P/L= 1/57, which corresponds to a peptide to lipid
at amolar ratio of P/L=1/62.5, which also corresponds to a charge ratio of 1. In contrast to
icity of 5.23 nm. TheMICs andMIC-equivalent P/Lmolar ratio of eachpolymer are provided
Fig. 4. Polymer-induced cubic phases are characterized byNGC. (a) ThemeasuredQ po-
sitions of the diffraction peaks were plotted for polymers A and C-2 to show indexing of
the cubic phases. The slopes of the linear regressions correspond to their lattice parame-
ters, which were 17.29 nm and 20.59 nm, respectively. (b) A 3D illustration of the Pn3m
cubic phase, which is characterized by negative Gaussian curvature at every point on the
surface. Negative Gaussian curvature has a saddle-splay shape, with positive (+) curva-
ture in one direction and negative (−) curvature in the perpendicular direction. (c) Neg-
ative Gaussian curvature can be found at the interior surface of a pore (1), the base of blebs
(2) and rod-like projections (3), and the necks of buds (4).
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aQ_C-2 = 20.59 nm (P/L = 1/62.5), and the other had integral Q-ratios
from a lamellar phase with lattice parameter dC-2 ≈ 5.10 nm (across
all tested P/L). In contrast toA and C-2, exposure ofB to the lipid vesicles
showed only a lamellar phase with a periodicity of dB≈ 5.23 nm, indic-
ative of inter-membrane attractionwithout the generation of signiﬁcant
curvature (Fig. 3b). The lattice parameters of each of the cubic phases
were calculated by the slope of a linear regression through the set of
points corresponding to the reﬂections, with each point deﬁned by co-
ordinates for the measured Q-position and its assigned reﬂection
(Fig. 4a). Both the Pn3m and Im3m are bicontinuous cubic phases
consisting of two sets of non-intersecting water channels separated by
a lipid bilayer (Fig. 4b) [89,90]. The midplane of this bilayer traces a
minimum surface characterized by NGC, also known as saddle-splay
curvature, at every point. While bilayer saddle-splay curvature is dis-
tinct from self-connected monolayer saddle-splay curvature, such as
that found in toroidal pores, each monolayer in a bicontinuous cubic
phase is characterized by NGC at every point of the surface. NGC is the
saddle-shaped curvature observed along the inside of toroids and at
the bases of buds and blebs (Fig. 4c). Previously we found a strong cor-
relation between AMP-induced formation of cubic phases and AMP-
induced membrane permeation [7,91]. While both 2D membrane per-
meation (vesicle leakage and membrane permeabilization) and bulk
3D lipid system cubic phase generation (SAXS experiments) require
NGC, the precise quantitative amount of NGC for each outcome is ex-
pected in general to be different. Our observations with model E. coli
membranes show that two of the three nylon-3 polymers tested with
SAXS, A and C-2, formed cubic phases, suggesting that these polymers
may permeate membranes through the induction of NGC in a manner
consistent with that of natural AMPs. The remaining polymer, B, does
not appear to disrupt membranes due to the absence of cubic phases.Interestingly, this observation is consistent with the MIC measured for
B, as described below.
AMP selectivity against bacteria over animal cells is believed to be a
consequence of their membrane compositional differences. Based on
previous studies, amphipathic AMPs are believed to disrupt bacterial
membranes through a combination of electrostatic and hydrophobic ef-
fects [6,8–10,16–18]. Bacterialmembranes contain large amounts of an-
ionic lipids such as PG, negative intrinsic curvature lipids such as PE, and
also lipids such as CL that have both anionic and negative intrinsic cur-
vature characteristics. These lipids are less common in the outer leaﬂets
of animal cell membranes, which are rich in neutral zwitterionic lipids
such as PC [7,8,16]. A range of lipid compositions have been reported
for bacterialmembranes [58–65]. To the origin of prokaryote vs. eukary-
ote selectivity of the nylon-3 polymers, we systematically examined
how varying the membrane composition affects the ability of the
polymers to restructure vesicles. We constructed SUVs with ternary
DOPG/DOPE/DOPC lipid compositions with a constant anionic charge
(DOPG = 20%) typical of bacterial membranes [92,93]. DOPG and
DOPC are characterized by having zero intrinsic curvature (C0 ≈ 0),
whereas DOPE and CL have negative intrinsic curvature (C0 b 0).
Enriching a membrane with these negative intrinsic curvature lipids
will shift the monolayer intrinsic curvature toward more negative
values. Thus, by ﬁxing the DOPG content to 20%, we are able to indepen-
dently tune the ratio of DOPE/DOPC and consequently membrane cur-
vature. Phase diagrams for polymers A, B, and C-2 (Fig. 5) illustrate
that the general trend for decreasing DOPE/DOPC was the suppression
of nonlamellar phase formation. More speciﬁcally, reduction of DOPE/
DOPC membrane content to 60/20 extinguished the cubic phases, to
leave only the lamellar phase. This observation further suggests that
the nylon-3 polymers require high PE content of approximately 80% to
generate NGC in lipid membranes. The phase diagram for polymer A
at DOPG/DOPE/DOPC= 20/80/0 depicts a progression of inverted hex-
agonal phase (HII)→ QII→ Lα as P/L increased to large values, with the
induction of a cubic phase at a P/L charge ratio of ~1 (equivalent
to molar ratio of P/L = 1/57). For an E. coli MIC assay, this P/L ratio
of 1/57 corresponds to a polymer concentration of approximately
1.4 ng/mL (see Supplemental Information), which is drastically less
than observed MICs as expected: structural changes in the membrane
from NGC generation (such as pore formation) accumulate as the poly-
mer concentration increases, and eventually culminate in the MIC.
Similarly, the phase diagram for polymer C-2 indicates cubic
phase generation at approximately the P/L charge ratio of 1 (molar
ratio P/L = 1/62.5). Unlike the two previous polymers, B displayed
only lamellar phases over the entire range of tested P/L ratios and
membrane compositions. An additional set of ternary membranes of
DOPG/DOPE/CLwas testedwithA, which also resulted in the generation
of Pn3m cubic phases. For these lipid compositions, althoughwe also ob-
served nonlamellar phase suppression with decreasing DOPE/CL, cubic
phaseswere induced at a lower PE content of 60%. This ﬁnding is consis-
tent with previous studies that have shown that CL lipids can substitute
for PE in certain conditions [57,94]. Because membrane lipid composi-
tions vary between bacteria species and can undergo modiﬁcation,
we evaluated the robustness of curvature generation among a range
of model membranes of different compositions. The preference for
these nylon-3 polymers to generate cubic phases at a high PE content
of 60–80% points to amechanismof selectivity for bacterial membranes,
such as that of E. coli, which has a composition of PG/PE/CL≈ 20/70/10–
20/75/5 [58,63].We note that this mechanism is cognate with those ob-
served for natural and synthetically derived AMPs [7,19,20,49,95].
3.3. Minimum inhibitory concentration (MIC) values of nylon-3 polymers
against E. coli correspond with NGC generation observed in SAXS studies
Antimicrobial activity of polymers A, B, and C-2 against E. coli was
assessed by measuring their MICs. SAXS data collected previously on
these nylon-3 polymers, with bacteria and eukaryotic-like model
Fig. 5. MIC values of polymers against E. coli correspond with structural changes in model membranes. Phase diagrams of structural changes induced by polymers A, B, and C-2 in
ternarymembranes composed of DOPG/DOPE/CL and DOPG/DOPE/DOPCwith ﬁxed DOPG content at 20%. Symbols used to indicate phases: open blue squares (QII), solid green hexagons
(HII), open red circles (Lα), and solid black circles (unilamellar). Table shows E. coliMICs and ability of each polymer to generate NGC in model membranes, with checkmarks indicating
existence of cubic phases and Xs indicating their absence. The MICs and MIC-equivalent P/L molar ratio of each polymer are provided for comparison.
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following compositions were used to model PE-rich prokaryotic
membranes: DOPG/DOPE/CL = 10/80/10 and 20/60/20, DOPG/DOPE/
DOPC = 20/80/0 and 20/60/20, and DOPS/DOPE = 20/80 [7,49,93].
The ﬁrst three of these membranes served speciﬁcally to mimic that of
E. coli, which is composed of PG/PE/CL≈ 20/70-75/5-10 [58,63]. Mem-
branes with decreased PE content served as eukaryotic-like models,
which included the following: DOPG/DOPE/DOPC = 20/40/40, 20/30/
50, 20/20/60, and 20/10/70. In general, we found that the presence of
NGC, which allows for the permeation of membranes and cellular
entry of these polymers, correlates to their bactericidal ability against
E. coli. The polymers with low MICs (A and C-2) were able to induce
cubic phases rich in NGC. However, polymer with a high MIC (B) was
unable to induce cubic phases.
Polymer A induced cubic phases in the three membrane composi-
tions that mimicked E. coli, which suggests that it destabilizes and per-
meates E. coli membranes by generating NGC. Its low MIC against
E. coli, at 50 μg/mL, further supports the correspondence of induced
membrane disruption with bacterial killing. Similarly, polymer C-2
was observed to generate NGC in the E. coli model membrane DOPG/
DOPE = 20/80 and had a potent MIC of 6.25 μg/mL. For A and C-2,
therewas diminished to noNGC generation formembranes that deviat-
ed from E. coli compositions. Because they exclusively induced NGC in
compositions mimicking E. colimembranes, we can infer selectivity of
these nylon-3 polymers for prokaryotic over eukaryotic membranes.
On the contrary, recall polymer B induced only lamellar phases across
the tested DOPG/DOPE/DOPC membranes. The absence of NGC genera-
tion suggests little to no membrane permeation. The high MIC value of
400 μg/mL for B further indicates low antimicrobial activity, which
would result from the lack of both membrane permeation and DNA
binding, the latter because this polymer is unable to traverse the cellular
membrane.
We hypothesize that the lower antimicrobial activity andmembrane
activity of polymer Bmay be the result of an overall lower hydrophobic-
ity in comparison with the other tested polymers, perhaps due to the
absence of a p-(tert-butyl)benzoyl unit at the N-terminus and higher
cationic charge resulting from 63% charged units of a longer chain
length [53]. Lower hydrophobicity would decrease the tendency of the
polymer to insert into the lipid core of membranes, which is necessary
for permeation. Moreover, lower hydrophobicity and higher cationic
charge of polymer B are in agreement with its decreased antimicrobial
activity based on previously established design principles for AMPs [7].
4. Conclusions
We have demonstrated that the antibacterial activity of nylon-3
polymers can be attributed to two interdependent channels of action.
These polymers are able to permeate bacterial membranes and to bind
to intracellular targets such as DNA. The bactericidal activity of these
polymers can be further correlated with their ability to generate cubic
phases rich in NGC, which is topologically necessary for membrane-
disruptive processes. Ablation of membrane activity will necessarily
suppress binding to an intracellular target such as DNA. Our ﬁndings
suggest that these polymers operate with a concentration-dependent
mechanism of action. Polymer concentrations near theMBC allow poly-
mer molecules to cross cell membranes and bind to DNA without com-
plete membrane disruption. However, at polymer concentrations that
signiﬁcantly exceed the MBC, complete disruption of the membrane is
possible.
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